🔓 Unlock the full profile of Michael Singer (Thirsty Brook Investments), including verified contact details, financial insights, and professional associations.
See Michael Singer Full ProfileBelow are the ✅ Verified Contact Details to help you connect directly:
Email: mic*****@thi******.com
Mobile: 60956*****
Estimated Net Worth 💰 : ₹0 – ₹500+ Cr (approx. $0 – $60M)
Key Insights You Should Know About This Individual
- Michael Singer currently serves as a Principal at Thirsty Brook Investments, contributing significant expertise in investment strategies since January 2016.
- From December 2022 to November 2023, Michael served as the Chairman and Chief Strategy Officer of Cartesian Therapeutics, demonstrating leadership in strategic decision-making for the organization.
- Co-founded Cartesian Therapeutics in April 2016 and served as the Chief Scientific Officer, playing a vital role in the organization's development and strategic direction.
- In January 2017, appointed as Entrepreneur-in-Residence at Yale University, providing mentorship and guidance to aspiring entrepreneurs and contributing to the academic community.
- Joined the Scientific Advisory Board of Yale University School of Medicine in January 2022, influencing research directions and fostering collaborations in biomedical sciences.
- Currently holds a position on the Board of Directors at Cartesian Therapeutics, providing insights and oversight to advance the company's mission and goals.
- Scheduled to join the Board of Directors at Boston Cell Standards in January 2024, indicating continuous involvement in innovative healthcare initiatives.
- Thirsty Brook Investments has maintained a stable headcount growth, reflecting the company’s focus on strategic investments and market stability under Michael's leadership.
- Michael Singer's career illustrates a consistent trajectory of leadership roles across academia and the biotechnology sector, contributing to advancements in each organization served.